KRSA Stock: Price, Earnings History and SEC Filings
Korsana Biosciences, Inc. (KRSA) last traded at $30.14, down 0.26% on the latest session and down 5.8% over the past month. In its most recent reported quarter (Dec 2025) earnings per share were $-1.33 against an analyst estimate of $-2.66, a beat of 50.0%.
$30.14 -0.26%
1 month-5.81%
52-week high$59.36
52-week low$7.19
Volume104,184
ExchangeNasdaqCM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
KRSA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Dec 2025 | Mar 30, 2026 | $-1.33 | $-2.66 | +50.00% |
KRSA beat the analyst EPS estimate in 1 of its last 1 reported quarters. Source: Nasdaq.
KRSA financial history
Revenue
Net income
Free cash flow
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $2M | -$4M | – | -170.1% | $-1.11 |
| 2024 | $2M | -$3M | – | -152.8% | $-1.21 |
| 2023 | $0 | -$5M | – | – | $-2.25 |
| 2022 | $297000 | -$44M | -$41M | -14841.1% | $-20.28 |
| 2021 | $4M | -$52M | -$37M | -1310.2% | $-1.32 |
| 2020 | $2M | -$78M | -$74M | -3388.6% | – |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for KRSA
SEC filing data is not available right now. You can search for KRSA on SEC EDGAR.
KRSA news
- Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength?Oct 27, 2026 · finance.yahoo.com
About Korsana Biosciences, Inc.
Korsana Biosciences, Inc. (KRSA) is a US-listed public company on Nasdaq.